Hangzhou debut draws hundreds of R&D leaders and procurement executives from global beauty brands.

HANGZHOU, China—March 20, 2026—Nanohealth Biotech concluded a landmark three-day run at the 2026 China International Exhibition for Personal Care & Home Care Ingredients (PCHi), held March 18–20 at the HangzhouGrand Exhibition. Exhibiting under booth number 2K32 and anchored by the theme "Precision Delivery, Targeted Repair," the company drew sustained foot traffic from R&D directors, formulators, and sourcing executives representing leading domestic and international beauty brands, ODM/OEM manufacturers, and research institutions.

The Hangzhou appearance marksNanohealth's second consecutive strong showing at PCHi, following a well-received debut in Guangzhou last year. Over the three-day event, the company's technical team conducted hundreds of one-on-one consultations, generated dozens of confirmed partnership intentions, and fielded significant demand for sample testing—outcomes the company attributes to growing industry appetite for science-backed, delivery-optimized cosmetic actives.

A Full-Spectrum View of the ACS Platform

Central toNanohealth's exhibition was a comprehensive showcase of its proprietary Active Carrier System (ACS) technology. Using a combination of technical diagrams, raw material displays, and finished formulation samples, the team demonstrated how encapsulation technologies—including liposomes, supramolecular structures, and nanoemulsions—address three persistent industry pain points: ingredient instability, poor transdermal penetration, and insufficient targeting precision.

The exhibition spanned eight functional categories: barrier repair, anti-aging,restoring, brightening, anti-hair loss, skin feel modulation, and more—presenting ACS not merely as an ingredient platform, but as an end-to-end formulation solution.

Hero Products Draw Professional Attention

Several flagship ingredients generated particular interest among attendees:

Biomimetic Multi-Ceramides Liposome —Positioned as a benchmark in the barrier repair segment, this ingredient is built on a framework the company describes as "one core innovation, triple biomimicry, six design principles." Clinical data from human trials showed a 25.03% improvement in skin hydration, drawing strong interest from brands seeking clinically substantiated repair solutions.

Stabilized Guaiazulene Niosome —Described by the team as a skin "calm stabilizer," this anti-redness active for sensitive skin addresses a longstanding formulation challenge: guaiacol-derived compounds are notoriously prone to photo-induced discoloration.Nanohealth's encapsulation technology resolves this instability while delivering compatibility across both oil and water phases.

LumiClear —Engineered specifically for oily skin types, LumiClear offers a "lightweight brightening" profile grounded in a human tyrosinase enzyme model. Its dual action—high-efficacy melanin inhibition combined with pore-minimizing and sebum-control benefits—was noted by attendees as addressing a meaningful gap in the current market.

ManeStay & Bitter Orange Calmskin —Supported by robust efficacy data—including a 61.61% reduction in hair loss at four weeks forManeStay and rapid desensitization results forBitter Orange Calmskin —these two ingredients underscoredNanohealth's expanding depth in scalp care and sensitive skin repair.

Beyond Transactions: Technical Co-Development Takes Center Stage

What distinguishedNanohealth's booth from a conventional sales exercise, according to the company, was the nature of conversations that unfolded. Technical specialists were on the floor throughout all three days, engaging in detailed troubleshooting around real formulation challenges—active degradation, insufficient absorption rates, multi-claim efficacy validation, and stability under varied processing conditions.

Many discussions, the company notes, moved well beyond ingredient procurement into joint exploration of product development roadmaps and emerging technology directions—a dynamic increasingly common as global brands look to raw material suppliers as strategic R&D partners rather than commodity vendors.

18 Years of Focused R&D, Validated by Market Response

Nanohealth Biotech, which marks 18 years of specialized research in active delivery systems, says the exhibition response affirmed both the commercial relevance of its technology platform and the effectiveness of its direct-engagement model. In addition to technical meetings, the booth's reception area hosted multiple rounds of a branded giveaway—including custom eco-bags, sunglasses, ambient lights, and aromatherapy products—drawing returning clients alongside new contacts in what the company described as a reunion atmosphere.

Looking Ahead

With PCHi Hangzhou behind it, Nanohealth says its focus turns to accelerating international market development and deepening its innovation pipeline in carrier-based active delivery. The company framed its broader mission as pushing the cosmetic ingredients industry toward greater efficacy precision, scientific rigor, and formulation intelligence.

"Every conversation at this show reminded us why we do what we do," a company representative said. "Our clients' challenges are our R&D agenda."

Suzhou Nanohealth Biotech Co., Ltd. 

Address: Room 1001,10#floor,Southern Citizen Center, No.39,Jinyuan Street,Suzhou Industrial Park

Tel/WhatsApp: +86 0512-62997335

Mobile: +86 150 5041 6887

E-mail: tommy.zhou@nanohealth.com.cn